Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > 4 cents a share
View:
Post by goldtech on Aug 09, 2023 10:53am

4 cents a share

So all these years of best in class and how everyone has done things wrong has gotten us absolutely nowhere. Now all these brainiacs we pay a crazy amount for have no clue what to do other then ask for more money for themselves, give huge share options and dilute the hell out of the company. Gene and Elliott the scammer started this BS and schools still out if Gail has a different approach. So far she has done nothing and this disgusting board has no clue.
Comment by M101 on Aug 09, 2023 2:17pm
It is looking self orchestrated like the end of Amorfix in 2015, but this time there is a product cycle ready to launch so even more devious.
Comment by Speyeder999 on Aug 09, 2023 5:16pm
Thought the price bottomed out last week this can easily drop another 50% when earnings come out next week. Company was sitting on S3.3M of cash and cash equivalents on March 31 and with a historical burn rate of 4M-5M $ per quarter, perhaps much lower this quarter, but regardless, numbers won't still be pretty. Gail mentionned something interesting at the annual meeting regarding shareprice ...more  
Comment by FarmerBetsy on Aug 09, 2023 7:52pm
You could be right Speyder but i don't think your going to see much on R&D. I think that dwindled at the end of last year. In fact if you notice in the SEC filing June1st in company transactions with related parties Cashman's research agreements with UBC came to an end of 2022. No mention of extension into 2023. Also mentions CMO Larry contract expires April 1, 2023. General and Admin ...more